SCHEMBL25629156

SCHEMBL25629156

c1ccc(-c2ccc(-c3ccc(N(c4ccc(-c5ccc6c(c5)oc5ccccc56)cc4)c4cccc5ccccc45)cc3)cc2-c2ccccc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 1/20 0.37
▸ HSD17B2 P37059 1/20 0.37
▸ MMP12 P39900 1/20 0.36
▸ MMP13 P45452 1/20 0.36
▸ HCRTR1 O43613 1/20 0.35
▸ DUSP3 P51452 1/20 0.34
▸ AHR P35869 2/20 0.34
▸ PLA2G2A P14555 3/20 0.34
▸ PLA2G4A P47712 3/20 0.34
▸ MEN1 O00255 4/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ RAB9A P51151 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17756924 0.94 DUSP3 (0.34) HSD17B1HSD17B2MMP12MMP13HCRTR1
SCHEMBL10110460 0.93 MMP12 (0.40) HSD17B1HSD17B2MMP12MMP13HCRTR1
SCHEMBL10110475 0.93 MMP12 (0.40) HSD17B1HSD17B2MMP12MMP13HCRTR1
SCHEMBL24999307 0.92 PLA2G2A (0.38) HSD17B1HSD17B2AHRPLA2G2APLA2G4A
SCHEMBL17756917 0.92 DUSP3 (0.34) HSD17B1HSD17B2MMP12MMP13HCRTR1
SCHEMBL25629035 0.92 PLA2G2A (0.38) HSD17B1HSD17B2AHRPLA2G2APLA2G4A
SCHEMBL10110476 0.92 PLA2G2A (0.40) HSD17B1HSD17B2MMP12MMP13HCRTR1
SCHEMBL10110455 0.92 PLA2G2A (0.40) HSD17B1HSD17B2MMP12MMP13HCRTR1
SCHEMBL20441539 0.91 AHR (0.37) MMP12MMP13DUSP3AHRPLA2G2A
SCHEMBL25629038 0.90 PLA2G2A (0.36) HSD17B1HSD17B2AHRPLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230200222-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-22 — — US disclosed
US-20230200222-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-22 — — US disclosed
US-11678569-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-06-13 — — US disclosed
US-11678569-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-06-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230200222-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM HSD17B1 3610/4885HSD17B2 3295/4885MMP12 2426/4885
US-11678569-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device PIEZO1, LEF1, L1CAM HSD17B1 3610/4885HSD17B2 3295/4885MMP12 2426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback